Detalles de la búsqueda
1.
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): II. Drugs in more advanced clinical development.
Epilepsia
; 63(11): 2883-2910, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35950617
2.
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): I. Drugs in preclinical and early clinical development.
Epilepsia
; 63(11): 2865-2882, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35946083
3.
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development.
Epilepsia
; 61(11): 2340-2364, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33190243
4.
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development.
Epilepsia
; 61(11): 2365-2385, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33165915
5.
Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017.
Drug Metab Dispos
; 47(2): 135-144, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30442649
6.
Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016.
Drug Metab Dispos
; 46(6): 835-845, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29572333
7.
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development.
Epilepsia
; 59(10): 1842-1866, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30368788
8.
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development.
Epilepsia
; 59(10): 1811-1841, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30368792
9.
Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).
Epilepsia
; 58(2): 181-221, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28111749
10.
e-PKGene: a knowledge-based research tool for analysing the impact of genetics on drug exposure.
Hum Genomics
; 5(5): 506-15, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21807605
11.
Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data.
Chem Res Toxicol
; 25(11): 2285-300, 2012 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-22823924
12.
Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN.
Epilepsia
; 53(1): 207-14, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22221159
13.
Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy.
Clin Pharmacokinet
; 61(9): 1219-1236, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35895276
14.
A useful tool for drug interaction evaluation: the University of Washington Metabolism and Transport Drug Interaction Database.
Hum Genomics
; 5(1): 61-72, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21106490
15.
Nefopam pharmacokinetics in patients with end-stage renal disease.
Anesth Analg
; 111(5): 1146-53, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20971961
16.
Inhibitors of Organic Anion-Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective.
J Clin Pharmacol
; 60(8): 1087-1098, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32196692
17.
Understanding the effects of Covid-19 through a life course lens.
Adv Life Course Res
; 45: 100360, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698274
18.
Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database.
Chem Res Toxicol
; 22(2): 294-8, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19216580
19.
Quantitative evaluation of pharmacokinetic inhibition of CYP3A substrates by ketoconazole: a simulation study.
J Clin Pharmacol
; 49(3): 351-9, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19246732
20.
A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV).
Epilepsy Res
; 153: 66-67, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30910314